Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration

Frontiers in Neurology

Volumn 4 MAR, Issue , 2013, Pages

  Burke, Kathleen A ^a   Yates, Elizabeth A ^a   Legleiter, Justin ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Amyloid disease; Huntington's disease; Lipid membranes; Parkinson's disease; Prion disease; Protein aggregation

Indexed keywords

ALPHA SYNUCLEIN; AMYLIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN C2; BETA SECRETASE; CALCITONIN; CELL SURFACE PROTEIN; GAMMA SECRETASE; GLUCAGON; HUNTINGTIN; INSULIN; LYSOZYME; PHOSPHATIDYLINOSITOL 3 KINASE; POLYGLUTAMINE; PRION PROTEIN;

AGE DISTRIBUTION; ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; BIOPHYSICS; BRAIN ATHEROSCLEROSIS; CELL AGGREGATION; CELL INCLUSION; CELL SURFACE; CELL SURVIVAL; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DNA FLANKING REGION; GOLGI COMPLEX; HUMAN; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SPACE; KINETICS; LEWY BODY; LIPID BILAYER; LIPID COMPOSITION; LIPID MEMBRANE; LIPID RAFT; LOCOMOTION; MEMBRANE FLUIDITY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NERVE DEGENERATION; NERVE FIBER; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STABILITY; PROTEIN TRANSPORT; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; THERMODYNAMICS;

EID: 84878218403     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00017     Document Type: Review

References (247)

1. Aguzzi, A., and Calella, A. M. (2009). Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105-1152.
2. Aisenbrey, C., Borowik, T., Bystrom, R., Bokvist, M., Lindstrom, F., Misiak, H., et al. (2008). How is protein aggregation in amyloidogenic diseases modulated by biological membranes? Eur. Biophys. J. 37, 247-255.
3. Anderson, M., Bocharova, O. V., Makarava, N., Breydo, L., Salnikov, V. V., and Baskakov, I. V. (2006). Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J. Mol. Biol. 358, 580-596.
4. Ansari, M. A., and Scheff, S. W. (2010). Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J. Neuropathol. Exp. Neurol. 69, 155-167.
5. Apetri, M. M., Maiti, N. C., Zagorski, M. G., Carey, P. R., and Anderson, V. E. (2006). Secondary structure of alpha-synuclein oligomers: characterization by Raman and atomic force microscopy. J. Mol. Biol. 355, 63-71.
6. Arispe, N., Pollard, H. B., and Rojas, E. (1993a). Giant multilevel cation channels formed by alzheimer-disease amyloid beta-protein A-beta-P-(1-40) in bilayer-membranes. Proc. Natl. Acad. Sci. U.S.A. 90, 10573-10577.
7. Arispe, N., Rojas, E., and Pollard, H. B. (1993b). Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U.S.A. 90, 567-571.
8. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., and Finkbeiner, S. (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810.
9. Ashley, R. H., Harroun, T. A., Hauss, T., Breen, K. C., and Bradshaw, J. P. (2006). Autoinsertion of soluble oligomers of Alzheimer's A beta(1-42) peptide into cholesterol-containing membranes is accompanied by relocation of the sterol towards the bilayer surface. BMC Struct. Biol. 6:21. doi:10.1186/1472-6807-6-21
10. Atwal, R. S., Desmond, C. R., Caron, N., Maiuri, T., Xia, J., Sipione, S., et al. (2011). Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat. Chem. Biol. 7, 453-460.
11. Atwal, R. S., Xia, J., Pinchev, D., Taylor, J., Epand, R. M., and Truant, R. (2007). Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet. 16, 2600-2615.
12. Bauer, H. H., Aebi, U., Haner, M., Hermann, R., Muller, M., Arvinte, T., et al. (1995). Architecture and polymorphism of fibrillar supramolecular assemblies produced by in-vitro aggregation of human calcitonin. J. Struct. Biol. 115, 1-15.
13. Berriman, J., Serpell, L. C., Oberg, K. A., Fink, A. L., Goedert, M., and Crowther, R. A. (2003). Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc. Natl. Acad. Sci. U.S.A. 100, 9034-9038.
14. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., et al. (2010). EGCG remodels mature a-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. U.S.A. 107, 7710-7715.
15. Blackley, H. K. L., Sanders, G. H. W., Davies, M. C., Roberts, C. J., Tendler, S. J. B., and Wilkinson, M. J. (2000). In-situ atomic force microscopy study of β-amyloid fibrillization. J. Mol. Biol. 298, 833-840.
16. Bokvist, M., Lindstrom, F., Watts, A., and Grobner, G. (2004). Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring Versus accelerated surface fibril formation. J. Mol. Biol. 335, 1039-1049.
17. Bouchard, M., Zurdo, J., Nettleton, E. J., Dobson, C. M., and Robinson, C. V. (2000). Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9, 1960-1967.
18. Braak, H., and Del Tredici, K. (2011). Alzheimer's pathogenesis: is there neuron-to-neuron propagation? Acta Neuropathol. 121, 589-595.
19. Braak, H., Del Tredici, K., Rub, U., De Vos, R. A. I., Steur, E., and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211.
20. Burke, K. A., Godbey, J., and Legleiter, J. (2011). Assessing mutant huntingtin fragment and polyglutamine aggregation by atomic force microscopy. Methods 53, 275-284.
21. Burke, K. A., Yates, E. A., and Legleiter, J. (2013). Amyloid-forming proteins alter the local mechanical properties of lipid membranes. Biochemistry 52, 808-817.
22. Capone, R., Jang, H., Kotler, S. A., Kagan, B. L., Nussinov, R., and Lal, R. (2012). Probing structural features of Alzheimer's amyloid-β pores in bilayers using site-specific amino acid substitutions. Biochemistry 51, 776-785.
23. Capone, R., Quiroz, F. G., Prangkio, P., Saluja, I., Sauer, A. M., Bautista, M. R., et al. (2009). Amyloid-β-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy. Neurotox. Res. 16, 1-13.
24. Castagnet, P. I., Golovko, M. Y., Barcelo-Coblijn, G. C., Nussbaum, R. L., and Murphy, E. J. (2005). Fatty acid incorporation is decreased in astrocytes cultured from a-synuclein gene-ablated mice. J. Neurochem. 94, 839-849.
25. Caughey, B. W., Dong, A., Bhat, K. S., Ernst, D., Hayes, S. F., and Caughey, W. S. (1991). Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 30, 7672-7680.
26. Cecchi, C., Fiorillo, C., Baglioni, S., Pensalfini, A., Bagnoli, S., Nacmias, B., et al. (2007). Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts. Neurobiol. Aging 28, 863-876.
27. Chamberlain, A. K., Macphee, C. E., Zurdo, J., Morozova-Roche, L. A., Hill, H. A. O., Dobson, C. M., et al. (2000). Ultrastructural organization of amyloid fibrils by atomic force microscopy. Biophys. J. 79, 3282-3293.
28. Chen, J. J., and Yu, B. P. (1994). Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Radic. Biol. Med. 17, 411-418.
29. Chen, S. M., Berthelier, V., Hamilton, J. B., O'Nuallain, B., and Wetzel, R. (2002a). Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41, 7391-7399.
30. Chen, S. M., Ferrone, F. A., and Wetzel, R. (2002b). Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. U.S.A. 99, 11884-11889.
31. Chiti, F., and Dobson, C. M. (2006). Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75, 333-366.
32. Choe, M., Jackson, C., and Yu, B. P. (1995). Lipid-peroxidation contributes to age-related membrane rigidity. Radic. Biol. Med. 18, 977-984.
33. Choi, J. H., and Yu, B. P. (1995). Brain synaptosomal aging: free radicals and membrane fluidity. Radic. Biol. Med. 18, 133-139.
34. Choo-Smith, L. P., Garzon-Rodriguez, W., Glabe, C. G., and Surewicz, W. K. (1997). Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272, 22987-22990.
35. Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., et al. (2009). Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-U325.
36. Clayton, D. F., and George, J. M. (1998). The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249-254.
37. Cole, N. B., Murphy, D. D., Grider, T., Rueter, S., Brasaemle, D., and Nussbaum, R. L. (2002). Lipid droplet binding and oligomerization properties of the Parkinson's disease protein a-synuclein. J. Biol. Chem. 277, 6344-6352.
38. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998). Accelerated in vitro fibril formation by a mutant a-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320.
39. Conway, K. A., Lee, S. J., Rochet, J. C., Ding, T. T., Williamson, R. E., and Lansbury, P. T. (2000). Acceleration of oligomerization, not fibrillization, is a shared property of both a-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. U.S.A. 97, 571-576.
40. Crowther, R. A., and Goedert, M. (2000). Abnormal tau-containing filaments in neurodegenerative diseases. J. Struct. Biol. 130, 271-279.
41. Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., et al. (2004). Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 2070-2075.
42. Dante, S., Hauss, T., Steitz, R., Canale, C., and Dencher, N. A. (2011). Nanoscale structural and mechanical effects of beta-amyloid (1-42) on polymer cushioned membranes: a combined study by neutron reflectometry and AFM Force Spectroscopy. Biochim. Biophys. Acta 1808, 2646-2655.
43. Danzer, K. M., Krebs, S. K., Wolff, M., Birk, G., and Hengerer, B. (2009). Seeding induced by a-synuclein oligomers provides evidence for spreading of a-synuclein pathology. J. Neurochem. 111, 192-203.
44. Davidson, W. S., Jonas, A., Clayton, D. F., and George, J. M. (1998). Stabilization of a-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443-9449.
45. de Calignon, A., Polydoro, M., Suarez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., et al. (2012). Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697.
46. De Felice, F. G., Wu, D., Lambert, M. P., Fernandez, S. J., Velasco, P. T., Lacor, P. N., et al. (2008). Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol. Aging 29, 1334-1347.
47. Demuro, A., Smith, M., and Parker, I. (2011). Single-channel Ca2+ imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology. J. Cell Biol. 195, 515-524.
48. Di Pardo, A., Maglione, V., Alpaugh, M., Horkey, M., Atwal, R. S., Sassone, J., et al. (2012). Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc. Natl. Acad. Sci. U.S.A. 109, 3528-3533.
49. Dobson, C. M. (2003). Protein folding and misfolding. Nature 426, 884-890.
50. Drescher, M., Van Rooijen, B. D., Veldhuis, G., Subramaniam, V., and Huber, M. (2010). A stable lipid-induced aggregate of a-synuclein. J. Am. Chem. Soc. 132, 4080-4082.
51. Drolle, E., Gaikwad, R. M., and Leonenko, Z. (2012). Nanoscale electrostatic domains in cholesterol-laden lipid membranes create a target for amyloid binding. Biophys. J. 103, L27-L29.
52. Duffy, P. E., and Tennyson, V. M. (1965). Phase and electron microscopic observations of Lewy bodies and melanin granules in substantia nigra and locus caeruleus in Parkinsons disease. J. Neuropathol. Exp. Neurol. 24, 398-414.
53. Dzwolak, W., Smirnovas, V., Jansen, R., and Winter, R. (2004). Insulin forms amyloid in a strain-dependent manner: an FT-IR spectroscopic study. Protein Sci. 13, 1927-1932.
54. Eanes, E. D., and Glenner, G. G. (1968). X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16, 673-677.
55. Elfrink, K., Ollesch, J., Stohr, J., Willbold, D., Riesner, D., and Gerwert, K. (2008). Structural changes of membrane-anchored native PrP(C). Proc. Natl. Acad. Sci. U.S.A. 105, 10815-10819.
56. Engel, M. F. M., Vandenakker, C. C., Schleeger, M., Velikov, K. P., Koenderink, G. H., and Bonn, M. (2012). The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution. J. Am. Chem. Soc. 134, 14781-14788.
57. Evangelisti, E., Cecchi, C., Cascella, R., Sgromo, C., Becatti, M., Dobson, C. M., et al. (2012). Membrane lipid composition and its physicochemical properties define cell vulnerability to aberrant protein oligomers. J. Cell. Sci. 125, 2416-2427.
58. Fandrich, M. (2007). On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell. Mol. Life Sci. 64, 2066-2078.
59. Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S., Anthony, M. D., and Edwards, R. H. (2004). Lipid rafts mediate the synaptic localization of a-synuclein. J. Neurosci. 24, 6715-6723.
60. Frost, B., Jacks, R. L., and Diamond, M. I. (2009). Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845-12852.
61. Giacomelli, C. E., and Norde, W. (2003). Influence of hydrophobic Teflon particles on the structure of amyloid β-peptide. Biomacromolecules 4, 1719-1726.
62. Giacomelli, C. E., and Norde, W. (2005). Conformational changes of the amyloid beta-peptide (1-40) adsorbed on solid surfaces. Macromol. Biosci. 5, 401-407.
63. Glenner, G. G., Ein, D., Eanes, E. D., Bladen, H. A., Terry, W., and Page, D. L. (1971). Creation of amyloid fibrils from Bence Jones proteins in-vitro. Science 174, 712-714.
64. Goldsbury, C., Kistler, J., Aebi, U., Arvinte, T., and Cooper, G. J. S. (1999). Watching amyloid fibrils grow by time-lapse atomic force microscopy. J. Mol. Biol. 285, 33-39.
65. Goldsbury, C. S., Cooper, G. J. S., Goldie, K. N., Muller, S. A., Saafi, E. L., Gruijters, W. T. M., et al. (1997). Polymorphic fibrillar assembly of human amylin. J. Struct. Biol. 119, 17-27.
66. Golovko, M. Y., Faergeman, N. J., Cole, N. B., Castagnet, P. I., Nussbaum, R. L., and Murphy, E. J. (2005). a-synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of a-synuclein palmitate binding. Biochemistry 44, 8251-8259.
67. Goold, R., Rabbanian, S., Sutton, L., Andre, R., Arora, P., Moonga, J., et al. (2011). Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat. Commun. 2, 281.
68. Gorbenko, G. P., and Kinnunen, P. K. J. (2006). The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem. Phys. Lipids 141, 72-82.
69. Gorodinsky, A., and Harris, D. A. (1995). Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J. Cell Biol. 129, 619-627.
70. Gosavi, N., Lee, H. J., Lee, J. S., Patel, S., and Lee, S. J. (2002). Golgi fragmentation occurs in the cells with prefibrillar a-synuclein aggregates and precedes the formation of fibrillar inclusion. J. Biol. Chem. 277, 48984-48992.
71. Gray, J. J. (2004). The interaction of proteins with solid surfaces. Curr. Opin. Struct. Biol. 14, 110-115.
72. Griffin, M. D., Mok, M. L., Wilson, L. M., Pham, C. L., Waddington, L. J., Perugini, M. A., et al. (2008). Phospholipid interaction induces molecular-level polymorphism in apolipoprotein C-II amyloid fibrils via alternative assembly pathways. J. Mol. Biol. 375, 240-256.
73. Gu, X., Greiner, E. R., Mishra, R., Kodali, R., Osmand, A., Finkbeiner, S., et al. (2009). Serines 13 and 16 are critical determinants of full-length human mutant Huntingtin induced disease pathogenesis in HD mice. Neuron 64, 828-840.
74. Guo, J. L., and Lee, V. M. Y. (2011). Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J. Biol. Chem. 286, 15317-15331.
75. Gutekunst, C. A., Levey, A. I., Heilman, C. J., Whaley, W. L., Yi, H., Nash, N. R., et al. (1995). Identification and localization of Huntingtin in brain and human lymphoblastoid cell-lines with anti-fusion antibodies. Proc. Natl. Acad. Sci. U.S.A. 92, 8710-8714.
76. Hamaguchi, T., Eisele, Y. S., Varvel, N. H., Lamb, B. T., Walker, L. C., and Jucker, M. (2012). The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol. 123, 31-37.
77. Hansen, C., Angot, E., Bergstrom, A.-L., Steiner, J. A., Pieri, L., Paul, G., et al. (2011). a-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Ivest. 121, 715-725.
78. Harjes, P., and Wanker, E. E. (2003). The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem. Sci. 28, 425-433.
79. Hartley, D. M., Walsh, D. M., Ye, C. P. P., Diehl, T., Vasquez, S., Vassilev, P. M., et al. (1999). Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876-8884.
80. Hatters, D. M., Lawrence, L. J., and Howlett, G. J. (2001). Sub-micellar phospholipid accelerates amyloid formation by apolipoprotein C-II. FEBS Lett. 494, 220-224.
81. Hatters, D. M., Macphee, C. E., Lawrence, L. J., Sawyer, W. H., and Howlett, G. J. (2000). Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry 39, 8276-8283.
82. Hebda, J. A., and Miranker, A. D. (2009). The interplay of catalysis and toxicity by amyloid intermediates on lipid bilayers: insights from Type II diabetes. Ann. Rev. Biophys. 38, 125-152.
83. Hou, J. F., Cui, J., Yu, L. C., and Zhang, Y. (2009). Intracellular amyloid induces impairments on electrophysiological properties of cultured human neurons. Neurosci. Lett. 462, 294-299.
84. Hoyer, W. G., Cherny, D., Subramaniam, V., and Jovin, T. M. (2004). Rapid self-assembly of a-synuclein observed by in situ atomic force microscopy. J. Mol. Biol. 340, 127-139.
85. Hu, X., Crick, S. L., Bu, G., Frieden, C., Pappu, R. V., and Lee, J.-M. (2009). Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl. Acad. Sci. U.S.A. 106, 20324-20329.
86. Hung, A., Griffin, M. D., Howlett, G. J., and Yarovsky, I. (2008). Effects of oxidation, pH and lipids on amyloidogenic peptide structure: implications for fibril formation?. Eur. Biophys. J. 38, 99-110.
87. Jang, H., Zheng, J., and Nussinov, R. (2007). Models of β-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. Biophys. J. 93, 1938-1949.
88. Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S., and Langen, R. (2008). Structure of membrane-bound a-synuclein from site-directed spin labeling and computational refinement. Proc. Natl. Acad. Sci. U.S.A. 105, 19666-19671.
89. Jarrett, J. T., and Lansbury, P. T. (1993). Seeding one-dimensional crystallization of amyloid - a pathogenic mechanism in Alzheimers disease and scrapie. Cell 73, 1055-1058.
90. Jayaraman, M., Mishra, R., Kodali, R., Thakur, A. K., Koharudin, L. M. I., Gronenborn, A. M., et al. (2012). Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties. Biochemistry 51, 2706-2716.
91. Jensen, M. O., and Mouritsen, O. G. (2004). Lipids do influence protein function - the hydrophobic matching hypothesis revisited. Biochim. Biophys. Acta 1666, 205-226.
92. Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, G., and Goedert, M. (1998). Binding of a-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273, 26292-26294.
93. Jimenez, J. L., Guijarro, J. L., Orlova, E., Zurdo, J., Dobson, C. M., Sunde, M., et al. (1999). Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18, 815-821.
94. Jimenez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M., and Saibil, H. R. (2002). The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 99, 9196-9201.
95. Jimenez, J. L., Tennent, G., Pepys, M., and Saibil, H. R. (2001). Structural diversity of ex vivo amyloid fibrils studied by cryo-electron microscopy. J. Mol. Biol. 311, 241-247.
96. Jo, E., Darabie, A. A., Han, K., Tandon, A., Fraser, P. E., and Mclaurin, J. (2004). a-synuclein-synaptosomal membrane interactions - implications for fibrillogenesis. Eur. J. Biochem. 271, 3180-3189.
97. Jo, E. J., Mclaurin, J., Yip, C. M., St George-Hyslop, P., and Fraser, P. E. (2000). a-synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275, 34328-34334.
98. Jucker, M., and Walker, L. C. (2011). Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann. Neurol. 70, 532-540.
99. Kane, M. D., Lipinski, W. J., Callahan, M. J., Bian, F., Durham, R. A., Schwarz, R. D., et al. (2000). Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein-transgenic mice. J. Neurosci. 20, 3606-3611.
100. Kar, K., Hoop, C. L., Drombosky, K. W., Baker, M. A., Kodali, R., Arduini, I., et al. (2013). β-Hairpin-mediated nucleation of polyglutamine amyloid formation. J. Mol. Biol. doi:10.1016/j.jmb.2013.01.016
101. Kar, K., Jayaraman, M., Sahoo, B., Kodali, R., and Wetzel, R. (2011). Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat. Struct. Mol. Biol. 18, 328.
102. Kegel, K. B., Kim, M., Sapp, E., Mcintyre, C., Castano, J. G., Aronin, N., et al. (2000). Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J. Neurosci. 20, 7268-7278.
103. Kegel, K. B., Sapp, E., Alexander, J., Valencia, A., Reeves, P., Li, X., et al. (2009). Polyglutamine expansion in huntingtin alters its interaction with phospholipids. J. Neurochem. 110, 1585-1597.
104. Kegel, K. B., Sapp, E., Yoder, J., Cuiffo, B., Sobin, L., Kim, Y. J., et al. (2005). Huntingtin associates with acidic phospholipids at the plasma membrane. J. Biol. Chem. 280, 36464-36473.
105. Kim, D. H., and Frangos, J. A. (2008). Effects of amyloid β-peptides on the lysis tension of lipid bilayer vesicles containing oxysterols. Biophys. J. 95, 620-628.
106. Kim, S.-I., Yi, J.-S., and Ko, Y.-G. (2006). Amyloid β oligomerization is induced by brain lipid rafts. J. Cell. Biochem. 99, 878-889.
107. King, O. D., Gitler, A. D., and Shorter, J. (2012). The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 1462, 61-80.
108. Kirschner, D. A., Abraham, C., and Selkoe, D. J. (1986). X-ray-diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimers disease indcates cross-β conformation. Proc. Natl. Acad. Sci. U.S.A. 83, 503-507.
109. Knight, J. D., and Miranker, A. D. (2004). Phospholipid catalysis of diabetic amyloid assembly. J. Mol. Biol. 341, 1175-1187.
110. Kodali, R., and Wetzel, R. (2007). Polymorphism in the intermediates and products of amyloid assembly. Curr. Opin. Struct. Biol. 17, 48-57.
111. Kodali, R., Williams, A. D., Chemuru, S., and Wetzel, R. (2010). Aβ(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. J. Mol. Biol. 401, 503-517.
112. Kowalewski, T., and Holtzman, D. M. (1999). In situ atomic force microscopy study of Alzheimer's β-amyloid peptide on different substrates: new insights into mechanism of β-sheet formation. Proc. Natl. Acad. Sci. U.S.A. 96, 3688-3693.
113. Kremer, J. J., and Murphy, R. M. (2003). Kinetics of adsorption of β-amyloid peptide Aβ(1-40) to lipid bilayers. J. Biochem. Biophys. Methods 57, 159-169.
114. Kremer, J. J., Pallitto, M. M., Sklansky, D. J., and Murphy, R. M. (2000). Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes. Biochemistry 39, 10309-10318.
115. Kurouski, D., Dukor, R. K., Lu, X., Nafie, L. A., and Lednev, I. K. (2012). Spontaneous inter-conversion of insulin fibril chirality. Chem. Commun. 48, 2837-2839.
116. Kurouski, D., Lombardi, R. A., Dukor, R. K., Lednev, I. K., and Nafie, L. A. (2010). Direct observation and pH control of reversed supramolecular chirality in insulin fibrils by vibrational circular dichroism. Chem. Commun. 46, 7154-7156.
117. Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y. S., Viola, K. L., et al. (2004). Synaptic targeting by Alzheimer's-related amyloid β oligomers. J. Neurosci. 24, 10191-10200.
118. Langer, F., Eisele, Y. S., Fritschi, S. K., Staufenbiel, M., Walker, L. C., and Jucker, M. (2011). Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J. Neurosci. 31, 14488-14495.
119. Lansbury, P. T. (1997). Structural neurology: are seeds at the root of neuronal degeneration?. Neuron 19, 1151-1154.
120. Lansbury, P. T., and Lashuel, H. A. (2006). A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443, 774-779.
121. Lashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., et al. (2002). a-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol. 322, 1089-1102.
122. Lee, H. J., Choi, C., and Lee, S. J. (2002). Membrane-bound a-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277, 671-678.
123. Legleiter, J., Fryer, J. D., Holtzman, D. M., and Kowalewski, A. (2011). The modulating effect of mechanical changes in lipid bilayers caused by apoE-containing lipoproteins on Aβ induced membrane disruption. ACS Chem. Neurosci. 2, 588-599.
124. Legleiter, J., and Kowalewski, T. (2004). Atomic force microscopy of β-amyloid: static and dynamic studies of nanostructure and its formation. Methods Mol. Biol. 242, 349-364.
125. Legleiter, J., Lotz, G. P., Miller, J., Ko, J., Ng, C., Williams, G. L., et al. (2009). Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant Huntingtin fragment. J. Biol. Chem. 284, 21647-21658.
126. Legleiter, J., Mitchell, E., Lotz, G. P., Sapp, E., Ng, C., Difiglia, M., et al. (2010). Mutant Huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo. J. Biol. Chem. 285, 14777-14790.
127. Li, H., Ye, S., Wei, F., Ma, S., and Luo, Y. (2012). In situ molecular-level insights into the interfacial structure changes of membrane-associated prion protein fragment [118-135] investigated by sum frequency generation vibrational spectroscopy. Langmuir 28, 16979-16988.
128. Lin, H., Bhatia, R., and Lal, R. (2001). Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15, 2433-2444.
129. Lin, H., Zhu, Y. W. J., and Lal, R. (1999). Amyloid βprotein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles. Biochemistry 38, 11189-11196.
130. Lin, M.-S., Chen, L.-Y., Wang, S. S. S., Chang, Y., and Chen, W.-Y. (2008). Examining the levels of ganglioside and cholesterol in cell membrane on attenuation the cytotoxicity of beta-amyloid peptide. Colloids Surf. B Biointerfaces 65, 172-177.
131. Lin, M.-S., Chiu, H.-M., Fan, F.-J., Tsai, H.-T., Wang, S. S. S., Chang, Y., et al. (2007). Kinetics and enthalpy measurements of interaction between β-amyloid and liposomes by surface plasmon resonance and isothermal titration microcalorimetry. Colloids Surf. B Biointerfaces 58, 231-236.
132. Lindstrom, F., Bokvist, M., Sparrman, T., and Grobner, G. (2002). Association of amyloid-β peptide with membrane surfaces monitored by solid state NMR. Phys. Chem. Chem. Phys. 4, 5524-5530.
133. Lins, L., Flore, C., Chapelle, L., Talmud, P. J., Thomas, A., and Brasseur, R. (2002). Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III. Protein Eng. 15, 513-520.
134. Linse, S., Cabaleiro-Lago, C., Xue, W.-F., Lynch, I., Lindman, S., Thulin, E., et al. (2007). Nucleation of protein fibrillation by nanoparticles. Proc. Natl. Acad. Sci. U.S.A. 104, 8691-8696.
135. Lomakin, A., Chung, D. S., Benedek, G. B., Kirschner, D. A., and Teplow, D. B. (1996). On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl. Acad. Sci. U.S.A. 93, 1125-1129.
136. Martins, I. C., Kuperstein, I., Wilkinson, H., Maes, E., Vanbrabant, M., Jonckheere, W., et al. (2008). Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 27, 224-233.
137. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., et al. (2000). Dopaminergic loss and inclusion body formation in a-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269.
138. McLaurin, J., and Chakrabartty, A. (1996). Membrane disruption by Alzheimer β-amyloid peptides mediated through specific finding to either phospholipids or gangliosides - implications for neurotoxicity. J. Biol. Chem. 271, 26482-26489.
139. McLaurin, J., and Chakrabartty, A. (1997). Characterization of the interactions of Alzheimer β-amyloid peptides with phospholipid membranes. Eur. J. Biochem. 245, 355-363.
140. McLean, P. J., Kawamata, H., Ribich, S., and Hyman, B. T. (2000). Membrane association and protein conformation of a-synuclein in intact neurons - effect of Parkinson's disease-linked mutations. J. Biol. Chem. 275, 8812-8816.
141. Medeiros, L. A., Khan, T., El Khoury, J. B., Pham, C. L., Hatters, D. M., Howlett, G. J., et al. (2004). Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 279, 10643-10648.
142. Meyer, R. K., Mckinley, M. P., Bowman, K. A., Braunfeld, M. B., Barry, R. A., and Prusiner, S. B. (1986). Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 83, 2310-2314.
143. Meyer-Luehmann, M., Coomaraswamy, J., Bolmont, T., Kaeser, S., Schaefer, C., Kilger, E., et al. (2006). Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781-1784.
144. Michikawa, M., Gong, J. S., Fan, Q. W., Sawamura, N., and Yanagisawa, K. (2001). A novel action of Alzheimer's amyloid β-protein (Aβ): Oligomeric Aβ promotes lipid release. J. Neurosci. 21, 7226-7235.
145. Mirzabekov, T. A., Lin, M. C., and Kagan, B. L. (1996). Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271, 1988-1992.
146. Miura, T., Yoda, M., Takaku, N., Hirose, T., and Takeuchi, H. (2007). Clustered negative charges on the lipid membrane surface induce β-sheet formation of prion protein fragment 106-126. Biochemistry 46, 11589-11597.
147. Moores, B., Drolle, E., Attwood, S. J., Simons, J., and Leonenko, Z. (2011). Effect of surfaces on amyloid fibril formation. PLoS ONE 6:e25954. doi:10.1371/journal.pone.0025954
148. Morillas, M., Swietnicki, W., Gambetti, P., and Surewicz, W. K. (1999). Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274, 36859-36865.
149. Morriss-Andrews, A., and Shea, J.-E. (2012). Kinetic pathways to peptide aggregation on surfaces: the effects of β-sheet propensity and surface attraction. J. Chem. Phys. 136:065103. doi:10.1063/1.3682986
150. Mossuto, M. F., Dhulesia, A., Devlin, G., Frare, E., Kumita, J. R., De Laureto, P. P., et al. (2010). The non-core regions of human lysozyme amyloid fibrils influence cytotoxicity. J. Mol. Biol. 402, 783-796.
151. Mougenot, A.-L., Nicot, S., Bencsik, A., Morignat, E., Verchere, J., Lakhdar, L., et al. (2012). Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 33, 2225-2228.
152. Mucchiano, G. I., Haggqvist, B., Sletten, K., and Westermark, P. (2001). Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J. Pathol. 193, 270-275.
153. Munch, C., and Bertolotti, A. (2012). Propagation of the prion phenomenon: beyond the seeding principle. J. Mol. Biol. 421, 491-498.
154. Munishkina, L. A., Phelan, C., Uversky, V. N., and Fink, A. L. (2003). Conformational behavior and aggregation of a-synuclein in organic solvents: modeling the effects of membranes. Biochemistry 42, 2720-2730.
155. Murphy, R. M. (2002). Peptide aggregation in neurodegenerative disease. Annu. Rev. Biomed. Eng. 4, 155-174.
156. Naeem, A., and Fazili, N. (2011). Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins. Cell Biochem. Biophys. 61, 237-250.
157. Narayanan, V., and Scarlata, S. (2001). Membrane binding and self-association of a-synucleins. Biochemistry 40, 9927-9934.
158. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y. J., Wu, G. M., Anafi, D., et al. (1999). Both familial Parkinson's disease mutations accelerate a-synuclein aggregation. J. Biol. Chem. 274, 9843-9846.
159. Necula, M., Chirita, C. N., and Kuret, J. (2003). Rapid anionic micelle-mediated a-synuclein fibrillization in vitro. J. Biol. Chem. 278, 46674-46680.
160. Nelson, R., Sawaya, M. R., Balbirnie, M., Madsen, A. O., Riekel, C., Grothe, R., et al. (2005). Structure of the cross-βspine of amyloid-like fibrils. Nature 435, 773-778.
161. Nonaka, T., Watanabe, S. T., Iwatsubo, T., and Hasegawa, M. (2010). Seeded aggregation and toxicity of a-synuclein and tau: cellular moels of neurodegeneative disease. J. Biol. Chem. 285, 34885-34898.
162. Norlin, N., Hellberg, M., Filippov, A., Sousa, A. A., Gröbner, G., Leapman, R. D., et al. (2012). Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM. J. Struct. Biol. 180, 174-189.
163. Oesch, B., Westaway, D., Walchli, M., Mckinley, M. P., Kent, S. B., Aebersold, R., et al. (1985). A cellular gene encodes scrapie PrP 27-30 protein. Cell 40, 735-746.
164. Okada, T., Wakabayashi, M., Ikeda, K., and Matsuzaki, K. (2007). Formation of toxic fibrils of Alzheimer's amyloid β-protein-(1-40) by monosialoganglioside GM1, a neuronal membrane component. J. Mol. Biol. 371, 481-489.
165. Paleologou, K. E., Kragh, C. L., Mann, D. M. A., Salem, S. A., Al-Shami, R., Allsop, D., et al. (2009). Detection of elevated levels of soluble-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132, 1093-1101.
166. Pan, K.-M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., et al. (1993). Conversion of a-helices into β-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 90, 10962-10966.
167. Panchal, M., Loeper, J., Cossec, J.-C., Perruchini, C., Lazar, A., Pompon, D., et al. (2010). Enrichment of cholesterol in microdissected Alzheimer's disease senile plaques as assessed by mass spectrometry. J. Lipid Res. 51, 598-605.
168. Pandey, A. P., Haque, F., Rochet, J.-C., and Hovis, J. S. (2009). Clustering of a-synuclein on supported lipid bilayers: role of anionic lipid, protein, and divalent ion concentration. Biophys. J. 96, 540-551.
169. Paravastu, A. K., Petkova, A. T., and Tycko, R. (2006). Polymorphic fibril formation by residues 10-40 of the Alzheimer's β-amyloid peptide. Biophys. J. 90, 4618-4629.
170. Pedersen, J. S., Dikov, D., Flink, J. L., Hjuler, H. A., Christiansen, G., and Otzen, D. E. (2006). The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. J. Mol. Biol. 355, 501-523.
171. Penney, J. B., Vonsattel, J. P., Macdonald, M. E., Gusella, J. F., and Myers, R. H. (1997). CAG repeat number governs the development rate of pathology in Huntington's disease. Ann. Neurol. 41, 689-692.
172. Petkova, A. T., Leapman, R. D., Guo, Z. H., Yau, W. M., Mattson, M. P., and Tycko, R. (2005). Self-propagating, molecular-level polymorphism in Alzheimer's β-amyloid fibrils. Science 307, 262-265.
173. Pifer, P. M., Yates, E. A., and Legleiter, J. (2011). Point mutations in Aβ result in the formation of distinct polymorphic aggregates in the presence of lipid bilayers. PLoS ONE 6:e16248. doi:10.1371/journal.pone.0016248
174. Pillot, T., Drouet, B., Pincon-Raymond, R. L., Vandekerckhove, J., Rosseneu, T., and Chambaz, J. (2000). A nonfibrillar form of the fusogenic prion protein fragment 118-135 induces apoptotic cell death in rat cortical neurons. J. Neurochem. 75, 2298-2308.
175. Pillot, T., Lins, L., Goethals, M., Vanloo, B., Baert, J., Vandekerckhove, J., et al. (1997). The 118-135 peptide lot the human prion protein forms amyloid fibrils and induces liposome fusion. J. Mol. Biol. 274, 381-393.
176. Popovych, N., Brender, J. R., Soong, R., Vivekanandan, S., Hartman, K., Basrur, V., et al. (2012). Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286). J. Phys. Chem. B 116, 3650-3658.
177. Pountney, D. L., Lowe, R., Quilty, M., Vickers, J. C., Voelcker, N. H., and Gai, W. P. (2004). Annular a-synuclein species from purified multiple system atrophy inclusions. J. Neurochem. 90, 502-512.
178. Pronchik, J., He, X., Giurleo, J. T., and Talaga, D. S. (2010). In vitro formation of amyloid from a-synuclein is dominated by reactions at hydrophobic interfaces. J. Am. Chem. Soc. 132, 9797-9803.
179. Prusiner, S. B. (1998). Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383.
180. Prusiner, S. B., and Hsiao, K. K. (1994). Human prion diseases. Ann. Neurol. 35, 385-395.
181. Qin, Z. H., Wang, Y. M., Sapp, E., Cuiffo, B., Wanker, E., Hayden, M. R., et al. (2004). Huntingtin bodies sequester vesicle-associated proteins by a polyproline-dependent interaction. J. Neurosci. 24, 269-281.
182. Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., et al. (2005). Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U.S.A. 102, 10427-10432.
183. Ramakrishnan, M., Jensen, P. H., and Marsh, D. (2003). a-Synuclein association with phosphatidylglycerol probed by lipid spin labels. Biochemistry 42, 12919-12926.
184. Ravits, J., Paul, P., and Jorg, C. (2007). Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68, 1571-1575.
185. Reiss, A. B., Siller, K. A., Rahman, M. M., Chan, E. S. L., Ghiso, J., and De Leon, M. J. (2004). Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol. Aging 25, 977-989.
186. Ren, P.-H., Lauckner, J. E., Kachirskaia, I., Heuser, J. E., Melki, R., and Kopito, R. R. (2009). Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol. 11, 219-225.
187. Rhee, S. K., Quist, A. P., and Lal, R. (1998). Amyloid β protein-(1-42) forms calcium-permeable, Zn2+-sensitive channel. J. Biol. Chem. 273, 13379-13382.
188. Robinson, P. J., and Pinheiro, T. J. (2010). Phospholipid composition of membranes directs prions down alternative aggregation pathways. Biophys. J. 98, 1520-1528.
189. Rocken, C., Tautenhahn, J., Buhling, F., Sachwitz, D., Vockler, S., Goette, A., et al. (2006). Prevalence and pathology of amyloid in atherosclerotic arteries. Arterioscler. Thromb. Vasc. Biol. 26, 676-677.
190. Ryan, T. M., Howlett, G. J., and Bailey, M. F. (2008). Fluorescence detection of a lipid-induced tetrameric intermediate in amyloid fibril formation by apolipoprotein C-II. J. Biol. Chem. 283, 35118-35128.
191. Sabate, R., Espargaro, A., Barbosa-Barros, L., Ventura, S., and Estelrich, J. (2012). Effect of the surface charge of artificial model membranes on the aggregation of amyloid β-peptide. Biochimie 94, 1730-1738.
192. Sabate, R., and Estelrich, J. (2005). Evidence of the existence of micelles in the fibrillogenesis of β-amyloid peptide. J. Phys. Chem. B 109, 11027-11032.
193. Sabate, R., Gallardo, M., and Estelrich, J. (2005). Spontaneous incorporation of beta-amyloid peptide into neutral liposomes. Colloids Surf. A Physicochem. Eng. Asp. 270, 13-17.
194. Sanghera, N., and Pinheiro, T. J. T. (2002). Binding of prion protein to lipid membranes and implications for prion conversion. J. Mol. Biol. 315, 1241-1256.
195. Sciacca, M. F. M., Kotler, S. A., Brender, J. R., Chen, J., Lee, D.-K., and Ramamoorthy, A. (2012). Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. Biophys. J. 103, 702-710.
196. Seilheimer, B., Bohrmann, B., Bondolfi, L., Muller, F., Stuber, D., and Dobeli, H. (1997). The toxicity of the Alzheimer's β-amyloid peptide correlates with a distinct fiber morphology. J. Struct. Biol. 119, 59-71.
197. Serem, W. K., Bett, C. K., Ngunjiri, J. N., and Garno, J. C. (2011). Studies of the growth, evolution, and self-aggregation of β-amyloid fibrils using tapping-mode atomic force microscopy. Microsc. Res. Tech. 74, 699-708.
198. Serio, T. R., Cashikar, A. G., Kowal, A. S., Sawicki, G. J., Moslehi, J. J., Serpell, L., et al. (2000). Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317-1321.
199. Seubert, P., Vigopelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., et al. (1992). Isolation and quantification of soluble Alzheimers β-peptide from biological fluids. Nature 359, 325-327.
200. Sharon, R., Bar-Joseph, I., Mirick, G. E., Serhan, C. N., and Selkoe, D. J. (2003). Altered fatty acid composition of dopaminergic neurons expressing a-synuclein and human brains with a-synucleinopathies. J. Biol. Chem. 278, 49874-49881.
201. Shen, L., Adachi, T., Vanden Bout, D., and Zhu, X. Y. (2012). A mobile precursor determines amyloid-β Peptide Fibril Formation at Interfaces. J. Am. Chem. Soc. 134, 14172-14178.
202. Shirendeb, U., Reddy, A. P., Manczak, M., Calkins, M. J., Mao, P., Tagle, D. A., et al. (2011). Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet. 20, 1438-1455.
203. Smith, D. P., Tew, D. J., Hill, A. F., Bottomley, S. P., Masters, C. L., Barnham, K. J., et al. (2008). Formation of a high affinity lipid-binding intermediate during the early aggregation phase of a-synuclein. Biochemistry 47, 1425-1434.
204. Snell, R. G., Macmillan, J. C., Cheadle, J. P., Fenton, I., Lazarou, L. P., Davies, P., et al. (1993). Relationship between trinucelotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4, 393-397.
205. Soto, C. (2011). Prion hypothesis: the end of the controversy?. Trends Biochem. Sci. 36, 151-158.
206. Sparr, E., Engel, M. F. M., Sakharov, D. V., Sprong, M., Jacobs, J., De Kruijff, B., et al. (2004). Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett. 577, 117-120.
207. Stahl, N., Borchelt, D. R., and Prusiner, S. B. (1990). Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase-C. Biochemistry 29, 5405-5412.
208. Steffan, J. S., Agrawal, N., Pallos, J., Rockabrand, E., Trotman, L. C., Slepko, N., et al. (2004). SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104.
209. Stohr, J., Watts, J. C., Mensinger, Z. L., Oehler, A., Grillo, S. K., Dearmond, S. J., et al. (2012). Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc. Natl. Acad. Sci. U.S.A. 109, 11025-11030.
210. Subasinghe, S., Unabia, S., Barrow, C. J., Mok, S. S., Aguilar, M. I., and Small, D. H. (2003). Cholesterol is necessary both for the toxic effect of Aβ peptides on vascular smooth muscle cells and for Aβ binding to vascular smooth muscle cell membranes. J. Neurochem. 84, 471-479.
211. Subramaniam, S., Sixt, K. M., Barrow, R., and Snyder, S. H. (2009). Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science 324, 1327-1330.
212. Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., and Blake, C. C. F. (1997). Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273, 729-739.
213. Tajima, S., Yokoyama, S., Kawai, Y., and Yamamoto, A. (1982). Behavior of apolipoprotein C-II in an aqueous solution. J. Biochem. 91, 1273-1279.
214. Teoh, C. L., Pham, C. L., Todorova, N., Hung, A., Lincoln, C. N., Lees, E., et al. (2011). A structural model for apolipoprotein C-II amyloid fibrils: experimental characterization and molecular dynamics simulations. J. Mol. Biol. 405, 1246-1266.
215. Terzi, E., Holzemann, G., and Seelig, J. (1997). Interaction of Alzheimer β-amyloid peptide(1-40) with lipid membranes. Biochemistry 36, 14845-14852.
216. Thakur, A. K., Jayaraman, M., Mishra, R., Thakur, M., Chellgren, V. M., Byeon, I.-J. L., et al. (2009). Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16, 380-389.
217. Thirumalai, D., Klimov, D. K., and Dima, R. I. (2003). Emerging ideas on the molecular basis of protein and peptide aggregation. Curr. Opin. Struct. Biol. 13, 146-159.
218. Tobin, A. J., and Signer, E. R. (2000). Huntington's disease: the challenge for cell biologists. Trends Cell Biol. 10, 531-536.
219. Tofoleanu, F., and Buchete, N.-V. (2012). Alzheimer's Aβ beta peptide interactions with lipid membranes fibrils, oligomers and polymorphic amyloid channels. Prion 6, 339-345.
220. Trevino, R. S., Lauckner, J. E., Sourigues, Y., Pearce, M. M., Bousset, L., Melki, R., et al. (2012). Fibrillar structure and charge determine the interaction of polyglutamine protein aggregates with the cell surface. J. Biol. Chem. 287, 29722-29728.
221. Tycko, R. (2004). Progress towards a molecular-level structural understanding of amyloid fibrils. Curr. Opin. Struct. Biol. 14, 96-103.
222. Tycko, R. (2006). Solid-state NMR as a probe of amyloid structure. Protein Pept. Lett. 13, 229-234.
223. Tycko, R., and Ishii, Y. (2003). Constraints on supramolecular structure in amyloid fibrils from two-dimensional solid-state NMR spectroscopy with uniform isotopic labeling. J. Am. Chem. Soc. 125, 6606-6607.
224. Valincius, G., Heinrich, F., Budvytyte, R., Vanderah, D. J., Mcgillivray, D. J., Sokolov, Y., et al. (2008). Soluble amyloid β-oligomers affect dielectric membrane properties by bilayer insertion and domain formation: implications for cell toxicity. Biophys. J. 95, 4845-4861.
225. van Echten-Deckert, G., and Walter, J. (2012). Sphingolipids: critical players in Alzheimer's disease. Prog. Lipid Res. 51, 378-393.
226. Varkey, J., Isas, J. M., Mizuno, N., Jensen, M. B., Bhatia, V. K., Jao, C. C., et al. (2010). Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J. Biol. Chem. 285, 32486-32493.
227. Vey, M., Pilkuhn, S., Wille, H., Nixon, R., Dearmond, S. J., Smart, E. J., et al. (1996). Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. U.S.A. 93, 14945-14949.
228. Volles, M. J., Lee, S. J., Rochet, J. C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., et al. (2001). Vesicle permeabilization by protofibrillar a-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812-7819.
229. Vonsattel, J. P. G., and DiFiglia, M. (1998). Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384.
230. Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M., and Muchowski, P. J. (2004). Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat. Struct. Mol. Biol. 11, 1215-1222.
231. Wakabayashi, M., and Matsuzaki, K. (2007). Formation of amyloids by Aβ-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol. J. Mol. Biol. 371, 924-933.
232. Westermark, P., Mucchiano, G., Marthin, T., Johnson, K. H., and Sletten, K. (1995). Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques. Am. J. Pathol. 147, 1186-1192.
233. Wetzel, R. (1994). Mutations and off-pathway aggregation of proteins. Trends Biotechnol. 12, 193-198.
234. Wetzel, R. (2012). Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence. J. Mol. Biol. 421, 466-490.
235. Williams, T. L., Day, I. J., and Serpell, L. C. (2010). The effect of Alzheimer's Aβ aggregation state on the permeation of biomimetic lipid vesicles. Langmuir 26, 17260-17268.
236. Williams, T. L., and Serpell, L. C. (2011). Membrane and surface interactions of Alzheimer's Aβ peptide - insights into the mechanism of cytotoxicity. FEBS J. 278, 3905-3917.
237. Williamson, R., Usardi, A., Hanger, D. P., and Anderton, B. H. (2008). Membrane-bound β-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J. 22, 1552-1559.
238. Wood, W. G., Schroeder, F., Igbavboa, U., Avdulov, N. A., and Chochina, V. V. (2002). Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol. Aging 23, 685-694.
239. Xu, J., Kao, S. Y., Lee, F. J. S., Song, W. H., Jin, L. W., and Yankner, B. A. (2002). Dopamine-dependent neurotoxicity of a-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8, 600-606.
240. Yates, E. A., Cucco, E. M., and Legleiter, J. (2011). Point Mutations in Aβ induce polymorphic aggregates at liquid/solid interfaces. ACS Chem. Neurosci. 2, 294-307.
241. Yip, C. M., Darabie, A. A., and Mclaurin, J. (2002). A(42-Peptide assembly on lipid bilayers. J. Mol. Biol. 318, 97-107.
242. Yip, C. M., Elton, E. A., Darabie, A. A., Morrison, M. R., and Mclaurin, J. (2001). Cholesterol, a modulator of membrane-associated Aβ-fibrillogenesis and neurotoxicity. J. Mol. Biol. 311, 723-734.
243. Yip, C. M., and McLaurin, J. (2001). Amyloid-β peptide assembly: a critical step in fibrillogenesis and membrane disruption. Biophys. J. 80, 1359-1371.
244. Yu, X., and Zheng, J. (2012). Cholesterol promotes the interaction of Alzheimer β-amyloid monomer with lipid bilayer. J. Mol. Biol. 421, 561-571.
245. Zhao, H. X., Tuominen, E. K. J., and Kinnunen, P. K. J. (2004). Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry 43, 10302-10307.
246. Zhu, M., Souillac, P. O., Ionescu-Zanetti, C., Carter, S. A., and Fink, A. L. (2002). Surface-catalyzed amyloid fibril formation. J. Biol. Chem. 277, 50914-50922.
247. Zhu, Y. J., Lin, H., and Lal, R. (2000). Fresh and nonfibrillar amyloid β protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP-channel-mediated cellular toxicity. FASEB J. 14, 1244-1254